acetaminophen has been researched along with hydroxychloroquine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Behpour, M; Ghoreishi, SM; Khoobi, A; Salavati-Niasari, M; Shaterian, M | 1 |
| Abd El Ghafar, MS; Abd-Elsalam, S; Abdo, EF; Ahmed, OA; Alboraie, M; Esmail, ES; Khalaf, M; Medhat, MA; Serangawy, GN; Soliman, S | 1 |
| Benzecry, V; Romagnuolo, M; Veraldi, S | 1 |
| Estadulho, GLD; Gonçalves, DA; Guima, KE; Martins, CA | 1 |
| Clark, S; Clees, WI; Elkin, KR; Elliott, HA; Hayden, KR; Jones, M; Mashtare, ML; Preisendanz, HE; Read, AF; Richard, TL; Shreve, MJ; Silverman, J; Veith, TL; Watson, JE | 1 |
1 review(s) available for acetaminophen and hydroxychloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for acetaminophen and hydroxychloroquine
| Article | Year |
|---|---|
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2020 |
5 other study(ies) available for acetaminophen and hydroxychloroquine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Design and evaluation of a highly sensitive nanostructure-based surface modification of glassy carbon electrode for electrochemical studies of hydroxychloroquine in the presence of acetaminophen.
Topics: Acetaminophen; Carbon; Electrochemistry; Electrodes; Hydroxychloroquine; Nanostructures | 2014 |
Urticaria as a first clinical manifestation of COVID-19.
Topics: Acetaminophen; Adult; Antiviral Agents; Cetirizine; COVID-19; COVID-19 Drug Treatment; Dermatologic Agents; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hydroxychloroquine; Male; Middle Aged; SARS-CoV-2; Urticaria | 2020 |
Multi-electrode platform for selective electrochemical sensing: 3D-printed insulating plastic is turned into a five-electrodes chip.
Topics: Acetaminophen; Electrodes; Hydroquinones; Hydroxychloroquine; Plastics; Printing, Three-Dimensional; Salicylic Acid | 2022 |
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.
Topics: Acetaminophen; Ampicillin; Animals; Anti-Bacterial Agents; COVID-19; Dexamethasone; Doxycycline; Environmental Monitoring; Humans; Hydroxychloroquine; Naproxen; Ofloxacin; Pandemics; Pennsylvania; Pharmaceutical Preparations; Soil; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |